Twilio To Rally Around 26%? Here Are 10 Top Analyst Forecasts For Tuesday
Q32 Bio Inc QTTB
$15.68
▲ +0.77%
(+$0.12)
📅 Earnings This Week
Open
$15.73
Prev Close
$15.56
Day Range
$15.00 – $15.99
52W Range
$1.57 – $23.57
Market Cap
$466.70M
P/E (TTM)
15.65
Beta
0.27
EPS (TTM)
$2.29
📋 Company Profile
| Industry | Biotechnology |
| Country | US |
| Exchange | NASDAQ NMS - GLOBAL MARKET |
| Currency | USD |
| IPO Date | 2018-03-28 |
| Shares Out. | 29,760,000 |
| Website | q32bio.com/ ↗ |
| Phone | 13026587581 |
| Employees | 22 |
| Net Income | -$7.6M |
| Total Assets | $63.7M |
| Total Liabilities | $17.4M |
| Equity | $46.3M |
About Q32 Bio Inc
Q32 Bio Inc is a clinical-stage biotechnology company focused on developing novel biologics to restore healthy immune balance in patients with alopecia areata (AA) and other autoimmune and inflammatory diseases driven by immune dysfunction. Its product candidate, bempikibart (ADX 914), is a fully human anti-interleukin 7 receptor alpha (IL-7R) antagonist monoclonal antibody designed to block signaling mediated by interleukin 7 (IL 7) and thymic stromal lymphopoietin (TSLP) and re-regulate adaptive immune function. The company has completed two Phase 2a clinical trials evaluating bempikibart, SIGNAL AA Part A for the treatment of alopecia areata and SIGNAL AD for the treatment of atopic dermatitis (AD).
Q32 Bio Inc is a publicly traded company under the ticker symbol QTTB on the NASDAQ NMS - GLOBAL MARKET, operating in the Biotechnology industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
📊 Analyst Ratings
11 analysts (2026-07-01)